Visceral leishmaniasis in renal transplant recipients: Successful treatment with liposomal amphotericin B (AmBisome)

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1308-1309

  Boletis, John N ^a   Pefanis, Angelos ^a,b   Stathakis, Charalampos ^a   Helioti, Helen ^a   Kostakis, Apostolos ^a   Giamarellou, Helen ^a  

^a Dept of Nephrology and Translation Infectious Disease Section 1st Dept of Propedeutic Medicine   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; MEGLUMINE ANTIMONATE; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOFLUORESCENCE TEST; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; VISCERAL LEISHMANIASIS;

EID: 0033018945     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514784     Document Type: Article

References (7)

1. 1. Ma DDF, Concannon AJ, Hayes J. Fatal leishmaniasis in a renal-transplant recipient. Lancet 1979;2:311-2.
2. 2. Anaissie EJ, Mattiuzzi GN, Miller CB, et al. Treatment of invasive fungal infections in renally impaired patients with amphotericin-B colloidal dispersion. Antimicrob Agents Chemother 1998;42:606-11.
3. 3. Ringden O, Andstrom E, Remberger M, Svahn BM, Tollemar J. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin. Bone Marrow Transplant 1994; 14(suppl 5): S10-4.
4. 4. Davidson RN, Di Martino L, Gradoni R, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-center trial. Q J Med 1994;87:75-81.
5. 5. Croft SL, Neal RA, Rao LS. Liposomes and other drug delivery systems in the treatment of leishmaniasis. In: Hart DT, ed. Leishmaniasis: the current status and new strategies for control. New York: Plenum Press, 1989:783-92.
6. 6. Janknegt R, de Marie S, Bakker-Woundenberg IAJM, et al. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 1992;23: 279-91.
7. 7. Dunan S, Mary C, Gambarelli F, et al. Quatre observations de leishmaniose viscerale chez des greffes du rein. Considerations pathogeniques et therapeutiques. Med Mal Infect 1993;23:297-301.